Sign In

Peter Croucher

Research Director at Garvan Institute of Medical Research

Professor Peter Croucher is a distinguished bone biologist and cancer researcher at the Garvan Institute of Medical Research in Sydney, Australia. He serves as the Director of the Cancer Plasticity and Dormancy Program, Head of the Bone Biology Laboratory, and a Senior Principal Fellow. His research focuses on cancer metastasis to the skeleton, particularly in diseases like multiple myeloma, and the molecular mechanisms underlying cancer cell dormancy and reactivation within bone. He has made significant contributions to understanding bone diseases and developing therapies like zoledronic acid and anti-RANKL, which are now globally used in clinical practice.134

Professor Croucher completed his PhD in cell biology at Cardiff University and conducted postdoctoral training at Cambridge and Sheffield Universities. He held academic positions at Oxford and Sheffield before joining Garvan in 2011. At Garvan, he has led initiatives such as the Healthy Ageing research theme and has developed groundbreaking techniques, including intravital imaging to study dormant cancer cells.125

He has published over 180 peer-reviewed articles and received numerous awards, including the 2023 Lawrence G. Raisz Award from the American Society for Bone and Mineral Research and the 2022 International Medal from the Society of Endocrinology (UK).15

Related Questions

What are some of Peter Croucher's most significant contributions to cancer research?
How has Peter Croucher's work impacted clinical practices in bone disease?
What is the Cancer Plasticity and Dormancy Program at the Garvan Institute?
Can you explain the concept of extrinsic control of cancer cell dormancy by bone cells?
What is the role of osteomorphs in bone resorption?
Peter Croucher
Peter Croucher, photo 1
Peter Croucher, photo 2
Add to my network

Location

Greater Sydney Area